Assura PLC Notice of Results & Investor Presentations (8205I)
21 April 2022 - 04:01PM
UK Regulatory
TIDMAGR
RNS Number : 8205I
Assura PLC
21 April 2022
21 April 2022
Assura plc
Notice of Year End Results & Investor Presentations
Assura plc ("the Company"), the UK's leading primary care
property investor and developer will announce Annual Results for
the year ended 31 March 2022 on Wednesday 18 May 2022.
A presentation for analysts and investors will be released at
7.00 am BST which can be viewed at the following link:
https://webcasting.brrmedia.co.uk/broadcast/625e82ca841dd838fd0be3a3
A live Q&A session with members of the senior management
team will be held at 11.30 am BST. The Q&A session can be
accessed either via the webcast link or conference call details
below.
Q&A option: webcast (audio):
https://webcasting.brrmedia.co.uk/broadcast/625e853d841dd838fd0be4c8
Q&A option: conference call: 0800 279 6877 or +44 (0)330 165
4012 (state "Assura Results Q&A" or code "1305353")
Investor Meet Company presentation
Separately, Jonathan Murphy (CEO) and Jayne Cottam (CFO) will
host a live presentation relating to the Annual Results for the
year ended 31 March 2022 via the Investor Meet Company platform on
Thursday 9 June 2022 at 11.30 am BST.
The presentation is open to all existing and potential
investors. Questions can be submitted pre-event via the Investor
Meet Company dashboard until 9.00 am the day before the meeting or
at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and
register to follow Assura plc via this link:
https://www.investormeetcompany.com/assura-plc/register-investor
Investors who already follow Assura plc on the Investor Meet
Company platform will automatically be invited to the event.
- Ends -
For more information, please contact:
Assura plc Tel: 01925 945354
David Purcell, Investor Relations E mail: Investor@assura.co.uk
Director
Finsbury Glover Hering Tel: 0207 251 3801
Gordon Simpson Email: Assura@Finsbury.com
James Thompson
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices,
is a UK REIT and long-term investor in and developer of primary
care property. The company, headquartered in Warrington, works with
GPs, health professionals and the NHS to create outstanding spaces
for health services in our communities. At 30 September 2021,
Assura's property portfolio was valued at GBP2,595 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real
Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORBKKBQCBKDKQB
(END) Dow Jones Newswires
April 21, 2022 02:01 ET (06:01 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Feb 2024 to Mar 2024
Assura (LSE:AGR)
Historical Stock Chart
From Mar 2023 to Mar 2024